Inventor · disambiguated record
Kai Lindenstruth
Also filed as: LINDENSTRUTH KAI
1 granted patent·10 pending applications·1 citations·filing 2007–2017
20Inventor score
Technology areasA61P
Top patents by PatentIndex Score
11 records- 0166US8039473B2Solid forms of [4-(3-fluoro-5-trifluoromethyl-pyridin-2-yl)-piperazin-1-yl-[5-methanesulfonyl-2-((S)-2,2,2-trifluoro-1-methyl-ethoxy)-phenyl]-methanoneHOFFMANN LA ROCHE·Filed 2010·Granted Oct 18, 2011·1 cites·13 claims
- 0260US2015140087A1Pharmaceutical Compositions Of Metabotropic Glutamate 5 Receptor (MGLU5) AntagonistsHOFFMANN LA ROCHE·Filed 2014·Application pending·0 cites
- 0355US2017202819A1Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonistsHOFFMANN LA ROCHE·Filed 2017·Application pending·0 cites
- 0455US2008214561A1Solid forms of [4-(3-fluoro-5-trifluoromethyl-pyridin-2-yl)-piperazin-1-yl-[5-methanesulfonyl-2-((s)-2,2,2-trifluoro-1-methyl-ethoxy)-phenyl]-methanoneBUBENDORF ANDRE·Filed 2007·Application pending·0 cites
- 0555US2013197225A1New Solid Forms of [4-(3-Fluoro-5-Trifluoromethyl-Pyridin-2-Yl)-Piperazin-1-Yl-[5-Methanesulfonyl-2-((S)-2,2,2-Trifluoro-1-Methyl-Ethoxy)-Phenyl]MethanoneHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 0650US2012309969A1Solid forms of [4-(3-fluoro-5-trifluoromethyl-pyridin-2-yl)-piperazin-1-yl-[5-methanesulfonyl-2-((s)-2,2,2-trifluoro-1-methyl-ethoxy)-phenyl]-methanoneBUBENDORF ANDRE·Filed 2012·Application pending·0 cites
- 0748US2011295007A1Solid forms of [4-(3-fluoro-5-trifluoromethyl-pyridin-2-yl)-piperazin-1-yl-[5-methanesulfonyl-2-((s)-2,2,2-trifluoro-1-methyl-ethoxy)-phenyl]-methanoneBUBENDORF ANDRE·Filed 2011·Application pending·0 cites
- 0846US2012039999A1Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonistsCHATTERJI ASHISH·Filed 2011·Application pending·0 cites
- 0945US2013331314A1Pharmaceutical composition for treating hcv infectionsHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 1039US2012114751A1Pharmaceutical composition for treating hcv infectionsLEIMINER ANDREAS·Filed 2011·Application pending·0 cites
- 1127US2012040008A1Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonistsCHATTERJI ASHISH·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kai Lindenstruth files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →